Cytori Therapeutics to Present at the Piper Jaffray 18th Annual Health Care Conference
Posted on: Wednesday, 29 November 2006, 00:00 CST
Cytori Therapeutics, Inc., (NASDAQ:CYTX) (Frankfurt:XMPA) announced today that Mark Saad, its Chief Financial Officer, will present and provide an audio webcast of the presentation at the Piper Jaffray 18th Annual Health Care Conference being held at The Pierre in New York on Friday, December 1st at 10:30 a.m. Eastern Standard Time (7:30 a.m. Pacific Standard Time).
The audio webcast may be accessed under "Events & Webcasts" in the Investor Relations section of the Company's website at http://www.cytoritx.com. The webcast will be available live and by replay one hour after the presentation on the company's website.
About Cytori Therapeutics
Cytori Therapeutics, Inc., (NASDAQ:CYTX) (Frankfurt:XMPA) is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution™ System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
Source: Business Wire
Related Articles
- Cytori Therapeutics to Webcast 2nd Quarter Results on August 8, 2008
- Cytori Therapeutics to Webcast 2nd Quarter Results on August 14, 2007
- Cytori Therapeutics to Webcast 2007 1st Quarter Results on May 11, 2007
- Cytori Therapeutics to Webcast 2006 4th Quarter and Year End Results on March 30, 2007
- Cytori Therapeutics Authors Review on Opportunity for Adipose Stem & Regenerative Cells in Cosmetic and Reconstructive Surgery
- Cytori Therapeutics to Webcast Second Quarter Financial Results on August 14, 2006
- Cytori Therapeutics Reports Benefit of Adipose Stem and Regenerative Cells in Reconstructive Surgery From Preclinical Study
- Cytori Therapeutics Demonstrates Adipose Stem and Regenerative Cells Reduce Incidence of Arrhythmia After Heart Attacks in Preclinical Study
- Cytori Therapeutics to Participate in Stem Cell Therapy Focus Session at the BIO CEO & Investor Conference
- Cytori Therapeutics Presents at Cell-Based Regenerative Medicine Symposium
User Comments (0)

RSS Feeds